Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 150

1.

Responding to the pandemic of falsified medicines.

Nayyar GML, Attaran A, Clark JP, Culzoni MJ, Fernandez FM, Herrington JE, Kendall M, Newton PN, Breman JG.

Am J Trop Med Hyg. 2015 Jun;92(6 Suppl):113-118. doi: 10.4269/ajtmh.14-0393. Epub 2015 Apr 20.

2.

Fighting trafficking of falsified and substandard medicinal products in Russia.

Fayzrakhmanov NF.

Int J Risk Saf Med. 2015;27 Suppl 1:S37-40. doi: 10.3233/JRS-150681.

PMID:
26639702
3.

Public health interventions to protect against falsified medicines: a systematic review of international, national and local policies.

Hamilton WL, Doyle C, Halliwell-Ewen M, Lambert G.

Health Policy Plan. 2016 Dec;31(10):1448-1466. Epub 2016 Jun 16. Review.

PMID:
27311827
4.
5.

Viewpoint: Counterfeit medicines and substandard medicines: Different problems requiring different solutions.

't Hoen E, Pascual F.

J Public Health Policy. 2015 Nov;36(4):384-9. doi: 10.1057/jphp.2015.22. Epub 2015 Jul 16.

PMID:
26178809
6.

Legal aspects of counteracting the trafficking of falsified medicines in the european union.

Pashkov V, Soloviov A, Olefir A.

Wiad Lek. 2017;70(4):843-849.

PMID:
29064815
7.

Combating poor-quality anti-malarial medicines: a call to action.

Bassat Q, Tanner M, Guerin PJ, Stricker K, Hamed K.

Malar J. 2016 Jun 1;15:302. doi: 10.1186/s12936-016-1357-8. Review.

8.

Stopping murder by medicine: introducing the Model Law on Medicine Crime.

Attaran A.

Am J Trop Med Hyg. 2015 Jun;92(6 Suppl):127-132. doi: 10.4269/ajtmh.15-0154. Epub 2015 Apr 20.

9.

Counterfeit drug penetration into global legitimate medicine supply chains: a global assessment.

Mackey TK, Liang BA, York P, Kubic T.

Am J Trop Med Hyg. 2015 Jun;92(6 Suppl):59-67. doi: 10.4269/ajtmh.14-0389. Epub 2015 Apr 20.

10.

A review of existing and emerging digital technologies to combat the global trade in fake medicines.

Mackey TK, Nayyar G.

Expert Opin Drug Saf. 2017 May;16(5):587-602. doi: 10.1080/14740338.2017.1313227. Epub 2017 Apr 7. Review.

PMID:
28349715
11.

Surveillance for falsified and substandard medicines in Africa and Asia by local organizations using the low-cost GPHF Minilab.

Petersen A, Held N, Heide L; Difäm-EPN Minilab Survey Group.

PLoS One. 2017 Sep 6;12(9):e0184165. doi: 10.1371/journal.pone.0184165. eCollection 2017.

12.

Falsification of medical products: criminal law mechanism combating threats to public health.

Gutorova N, Zhytnyi O, Soloviov O.

Wiad Lek. 2019;72(5 cz 1):856-861.

PMID:
31175785
13.

The global pandemic of falsified medicines: laboratory and field innovations and policy perspectives.

Nayyar GML, Breman JG, Herrington JE.

Am J Trop Med Hyg. 2015 Jun;92(6 Suppl):2-7. doi: 10.4269/ajtmh.15-0221. Epub 2015 Apr 20. No abstract available.

14.

The health consequences of falsified medicines- A study of the published literature.

Rahman MS, Yoshida N, Tsuboi H, Tomizu N, Endo J, Miyu O, Akimoto Y, Kimura K.

Trop Med Int Health. 2018 Dec;23(12):1294-1303. doi: 10.1111/tmi.13161. Epub 2018 Oct 22. Review.

15.

Prevalence and Estimated Economic Burden of Substandard and Falsified Medicines in Low- and Middle-Income Countries: A Systematic Review and Meta-analysis.

Ozawa S, Evans DR, Bessias S, Haynie DG, Yemeke TT, Laing SK, Herrington JE.

JAMA Netw Open. 2018 Aug 3;1(4):e181662. doi: 10.1001/jamanetworkopen.2018.1662.

16.

Global perspectives on ensuring the safety of pharmaceutical products in the distribution process
.

Jeong S, Ji E.

Int J Clin Pharmacol Ther. 2018 Jan;56(1):12-23. doi: 10.5414/CP203151.

PMID:
29154750
17.

[Fake drugs, what are we talking about? Counterfeit drugs, informal market, quality of pharmaceutical… Thought from an anthropological study led in Benin].

Baxerres C.

Bull Soc Pathol Exot. 2014 May;107(2):121-6. doi: 10.1007/s13149-014-0354-9. Epub 2014 Mar 17. French.

PMID:
24639135
18.

Collaborative health and enforcement operations on the quality of antimalarials and antibiotics in southeast Asia.

Yong YL, Plançon A, Lau YH, Hostetler DM, Fernández FM, Green MD, Sounvoravong S, Nara S, Boravann M, Dumrong T, Bangsawan N, Low MY, Lim CC, Ai RLC, Newton PN.

Am J Trop Med Hyg. 2015 Jun;92(6 Suppl):105-112. doi: 10.4269/ajtmh.14-0574. Epub 2015 Apr 20. Erratum in: Am J Trop Med Hyg. 2015 Oct 7;93(4):891.

19.
20.

Are we doing enough to prevent poor-quality antimalarial medicines in the developing world?

Walker EJ, Peterson GM, Grech J, Paragalli E, Thomas J.

BMC Public Health. 2018 May 15;18(1):630. doi: 10.1186/s12889-018-5521-7.

Supplemental Content

Support Center